Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo Nanotech Investing
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy Nanotech Investing
Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress Nanotech Investing
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer Nanotech Investing
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency Nanotech Investing
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update Nanotech Investing
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization Nanotech Investing
dynaCERT Announces Leadership Transition as Company Advances Global Commercial Expansion Cleantech Investing
Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults Nanotech Investing
